• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Prosensa Holding NV

+ Add to Watchlist

RNA:US

9.1500 USD 0.2600 2.76%

As of 20:10:00 ET on 08/28/2014.

Company Profile for Prosensa Holding NV (RNA)

Prosensa Holding NV is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on neuromuscular and neurodegenerative disorders, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.

Contact Information

Prosensa Holding NV

JH Oortweg 21
Leiden, NL-2333 CH
Netherlands
Phone: 31-71-33-22-100
Fax: 31-71-33-22-088

Key Executives for Prosensa Holding NV (RNA)

Hans G C P SchikanCEO/Member-Mgmt BoardBerndt A E ModigCFO/Member-Mgmt Board
Willem W Van WeperenChief Commercial OfficerGiles CampionSenior VP:Research & Dev
Luc DochezSenior VP:Bus Dev/Chief Bus Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil